Enterotoxigenic E. coli (ETEC): Characteristics, Virulence, Diarrhea & Diagnosis

  • Enterotoxigenic E. coli (ETEC) is defined as containing the E. coli strains that elaborate at least one member of two defined groups of enterotoxins: heat-stable toxin (ST) and heat-stable toxin (LT).
  • Enterotoxigenic Escherichia coli, or ETEC, is thus the name given to a group of E. coli that produces special toxins that stimulate the lining of the intestines causing them to secrete excessive fluid, producing diarrhea.
  • ETEC strains were first recognized as causes of diarrheal disease in piglets, where the disease continues to cause lethal infection in newborn animals.
  • Common serotypes associated are-06, 08, 0 15, 025, 0 27, 0 153, 0 159, etc.
Enterotoxigenic E. coli (ETEC)

Image Source: CDC and Johns Hopkins Bloomberg School of Public Health

Disease Caused

  • Enterotoxigenic E. coli (ETEC) is one of the most common causes of bacterial diarrheal disease in developing countries and in an estimated 30% of travelers to these countries with diarrheal disease.
  • The disease caused is named Traveler’s diarrhea and Weanling diarrhea (infant diarrhea) in developing countries.

Mode of Transmission

The infections are primarily acquired through consumption of fecally contaminated food or water. Person-to-person spread does not occur.

Toxins and Pathogenesis

Plasmid-mediated, heat-stable (ST) and heat-labile (LT) enterotoxins that stimulate hypersecretion of fluids and electrolytes/

  • The organisms colonize the surface of the small bowel mucosa and elaborate their plasmid-encoded enterotoxins, giving rise to a net secretory state.
  • ETEC strains cause diarrhea through the action of the enterotoxins LT and ST. These strains may express an LT only, an ST only, or both an LT and an ST.
  • Disease requires bacterial attachment to the small bowel epithelium by bacterial surface proteins (colonization factors [CF]) and elaboration of heat-stable and heat-labile enterotoxins.
  • The genes for the colonization factors and enterotoxins are encoded on a transmissible plasmid.
  • The colonization factors are subdivided into families (CFA/I, CFA/II, CFA/IV are the most common) and further subdivided by their antigenic properties (coli surface antigens [CS]). More than 20 CS colonization factors have been described, and host specificity is defined by their affinity for receptors on host cells.
  • ETEC produces two classes of enterotoxins: heat-stable toxins (STa and STb) and heat-labile toxins (LT-I, LT-II).
  • Heat-stable toxin STa is only associated with human disease, is found in 75% to 80% of ETEC either alone or associated with LT, and is responsible more commonly for severe disease than LT-only ETEC strains.
  • STa is a small monomeric peptide that binds to the transmembrane guanylate cyclase C receptor on the intestinal epithelium, leading to an increase in cyclic guanosine monophosphate (cGMP) and subsequent hypersecretion of fluids well as inhibition of fluid absorption.
  • Of the heat-labile toxins, LT-I is more commonly associated with human disease. LT-I is functionally and structurally similar to cholera toxin (80% homology) and consists of one A subunit and five identical B subunits.
  • The B subunits bind to the same receptor as cholera toxin (GM1 gangliosides), as well as other surface glycoproteins on epithelial cells in the small intestine. After endocytosis, the A subunit moves across the membrane of the vacuole and interacts with a membrane protein (Gs) that regulates adenylate cyclase. The net effect of this interaction is an increase in cyclic adenosine monophosphate (cAMP) levels, resulting in enhanced secretion of chloride and decreased absorption of sodium and chloride. These changes are manifested in watery diarrhea.
  • Exposure to the toxin also stimulates prostaglandin secretion and production of inflammatory cytokines, resulting in further fluid loss.

Signs, Symptoms, and Complications

Illness develops 1-3 days after exposure and symptoms rarely last more than 3 weeks.

The characteristic symptoms include:

  • Watery, non-bloody diarrhea
  • Abdominal cramps
  • Less commonly nausea and vomiting

Symptoms are similar to those of cholera but are usually milder, although mortality is high in malnourished individuals and in those with underlying diseases, particularly children and the elderly.

Diagnosis

Detection of ETEC has long relied on the detection of the enterotoxins LT and/or ST.

  • Commercial immunoassays are available for detecting ST in clinical specimens and cultures.
  • PCR assays used with clinical specimens.

Treatment

The illness usually lasts 3-4 days. Some infections may take a week or longer to resolve. Most patients recover with supportive measures alone and do not require hospitalization or antibiotics.

Prevention

Infection can be prevented by avoiding or safely preparing foods and beverages that could be contaminated with the bacteria, as well as washing hands with soap frequently.

For travelers in developing countries, ETEC infection can be prevented by avoiding foods and beverages that could be contaminated with bacteria.

References

  1. Murray, P. R., Rosenthal, K. S., & Pfaller, M. A. (2013). Medical microbiology. Philadelphia: Elsevier/Saunders
  2. Parija S.C. (2012). Textbook of Microbiology & Immunology.(2 ed.). India: Elsevier India.
  3. Sastry A.S. & Bhat S.K. (2016). Essentials of Medical Microbiology. New Delhi : Jaypee Brothers Medical Publishers.
  4. https://cmr.asm.org/content/11/1/142
  5. https://www.cdc.gov/ecoli/etec.html

About Author

Photo of author

Sagar Aryal, PhD

Dr. Sagar Aryal is a microbiologist, researcher, and science communicator from Nepal. He is also co-founder and Research Head of the Department of Natural Products at the Kathmandu Research Institute for Biological Sciences (KRIBS), where he leads research on natural product discovery and microbial biodiversity. Dr. Aryal earned his Ph.D. in Microbiology from Tribhuvan University, Kathmandu, Nepal, in 2025, supported by a DAAD Research Grant and a University Grants Commission (UGC) Nepal Ph.D. Fellowship. His research interests include Actinomycetes, Myxobacteria, microbial taxonomy, and natural products, particularly the discovery of bioactive compounds with potential pharmaceutical applications. He isolated and identified Nocardia nepalensis, a novel bacterial species from Nepal, contributing to understanding microbial diversity in the region. Dr. Aryal has published more than 16 research articles in international journals and contributed three book chapters to established academic publications. He has presented scientific research findings and developed international research collaborations through visits to more than 18 countries across Asia, Europe, North America, and Oceania. From 2023 to 2025, he served as the American Society for Microbiology (ASM) Young Ambassador to Nepal. Since December 2025, he has served as an Editorial Board Member of Scientific Reports, a Nature Portfolio journal. In recognition of his scientific contributions, Dr. Aryal received the NAST Science and Technology Youth Award 2025 from the Nepal Academy of Science and Technology. He previously received the Frs. Locke and Stiller Research Award (LSRA) for the 2017-2018 cycle from St. Xavier's College, Kathmandu, and a Nepal Academy of Science and Technology (NAST) Research Grant for 2017-2018. Alongside his scientific career, Dr. Aryal has more than 15 years of experience in blogging, content writing, and search engine optimization (SEO).

1 thought on “Enterotoxigenic E. coli (ETEC): Characteristics, Virulence, Diarrhea & Diagnosis”

Leave a Comment